Skip to Main Content

Bora Acquires Pyros Pharmaceuticals to Bolster Upsher-Smith Rare Disease Product Portfolio

Upsher-Smith Laboratories, LLC

Home
Products
Corporate Development
About Us
News
Careers
Contact Us
800-654-2299

Products
Corporate Development
About Us
Careers
Contact Us

News
800-654-2299

Summary of Financial Results for Fiscal Year Ended March 31, 2021

May 13, 2021
Company News

Share:

Share on Facebook
Share on Twitter
Share on LinkedIn
Share via Email

Sawai Receives Approvals for Eight Generic Drugs with 20 Strengths
FY2020 Financial Results for fiscal year ended March 31, 2021

Categories

Company News

Staying True to Our Roots

In 1919 our founder F.A. Upsher Smith harvested foxglove flowers on his Minnesota farm to extract the cardiac drug digitalis. In doing so, Upsher Smith yielded not only our first, foundational pharmaceutical product, but also a strong spirit of innovation that continues to inspire us today. Learn more about the history behind Upsher-Smith.

Facebook

© 2025 Upsher-Smith Laboratories, LLC. All Rights Reserved.

Site Credits
Terms and Conditions
Privacy Policy
Accessibility
Legal Notices

Careers

Join Our Team!

We’re hiring

Search Our Jobs

Close

You are now leaving Upsher-Smith.com

Upsher-Smith Laboratories, LLC is not responsible for content or policies on linked sites.

Ok